Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genizon BioSciences and London Genetics have announced an agreement under which they will collaborate to replicate discoveries made by Genizon in a genome-wide association study of schizophrenia.
Subscribe to our email newsletter
Under the research collaboration agreement, London Genetics’s partner, University College London (UCL), will replicate Genizon’s findings from the genome-wide association study that identified multiple genes associated with schizophrenia using DNA samples from the Quebec Founder Population. Genotyping of samples and statistical analyses of the data will be conducted at Genizon’s St. Laurent, Quebec research center.
John Hooper, president and CEO of Genizon, said: “We are delighted to be working with London Genetics and UCL. They have access to advanced expertise in schizophrenia research, and this collaboration will help replicate our discoveries in this disease.”